GETIB N Stock Overview
Provides products and solutions for operating rooms, intensive-care units, and sterilization departments.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Getinge AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr901.62 |
| 52 Week High | kr0 |
| 52 Week Low | kr0 |
| Beta | 0.85 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 91.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| GETIB N | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | 0% | 0% | 0% |
Return vs Industry: GETIB N exceeded the MX Medical Equipment industry which returned -2.1% over the past year.
Return vs Market: GETIB N underperformed the MX Market which returned 3.7% over the past year.
Price Volatility
| GETIB N volatility | |
|---|---|
| GETIB N Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: GETIB N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GETIB N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 11,056 | Mattias Perjos | www.getinge.com |
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; monitoring systems, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected devices, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products.
Getinge AB (publ) Fundamentals Summary
| GETIB N fundamental statistics | |
|---|---|
| Market cap | Mex$107.45b |
| Earnings (TTM) | Mex$4.06b |
| Revenue (TTM) | Mex$46.72b |
26.5x
P/E Ratio2.3x
P/S RatioIs GETIB N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GETIB N income statement (TTM) | |
|---|---|
| Revenue | kr29.25b |
| Cost of Revenue | kr15.38b |
| Gross Profit | kr13.88b |
| Other Expenses | kr11.33b |
| Earnings | kr2.54b |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Jul 18, 2023
| Earnings per share (EPS) | 9.34 |
| Gross Margin | 47.44% |
| Net Profit Margin | 8.69% |
| Debt/Equity Ratio | 14.2% |
How did GETIB N perform over the long term?
See historical performance and comparison